Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

25.97USD
23 Apr 2019
Change (% chg)

-- (--)
Prev Close
$25.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,314
52-wk High
$53.14
52-wk Low
$19.33

About

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2,... (more)

Overall

No Ratios Available.

Financials

  AUTL.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -- -- --
ROI: -- 8.91 13.83
ROE: -- 10.06 15.25

Earnings vs. Estimates